Abstract
Taenia crassiceps has been widely experimented as a model for in vitro and in vivo studies on drug responses. The purpose of this study was to treat BALB/c mice infected with T. crassiceps strain WFU with commercially available albendazole and to analyze the reduction in parasite infrapopulations. Here, we describe the reduction and apparent damage of T. crassicceps WFU cysticerci in infected mice after antihelminthic drug treatment and subsequent inoculation of those treated parasites into a naïve host. We were able to reduce significantly the parasite counts to 33 and 48 % after albendazole treatment for 20 or 25 days and compared with the untreated mice. We also observed morphological damage such as the partial blebbing in the tegument and parenchyma of treated parasites, as well as disorganized musculature and the loss of cell membranes in subtegumental tissue section. However, larvae from albendazole-treated mice inoculated into the next host were able to become re-established in the next murine host due, probably, to the survival of proliferative parasite cells.
Similar content being viewed by others
References
Brehm K (2010) Echinococcus multilocularis as an experimental model in stem cell research and molecular host-parasite interaction. Parasitology 137:537–555. doi:10.1017/S0031182009991727
Brunet LR, Finkelman FD, Cheever AW, Kopf MA, Pearce EJ (1997) IL-4 protects against TNF-alfa-mediated cachexia and death during acute schistosomiasis. J Immunol 159:777–785
Ceballos L, Elissondo C, Sánchez Bruni S, Denegri G, Lanusse C, Alvarez L (2011) Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice. Antimicrob Agents Chemother 55:5861–5867. doi:10.1128/AAC.05105-11
Cruz M, Cruz I, Horton J (1991) Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg 85:244–247
Dayan AD (2003) Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica 86:141-/159. doi:10.1016/S0001-706X(03)00031-7
Dissanayake S, Shahin A (2007) Induction of interferon-gamma by Taenia crassiceps glycans and Lewis sugars in naive BALB/c spleen and peritoneal exudate cells. Mol Immun 44:1623–1630. doi:10.1016/j.molimm.2006.08.019
Everhart ME, Kuhn RE, Zelmer DA (2004) Infrapopulation dynamics of a wild strain of Taenia crassiceps (WFU) (Cestoda: Taeniidae) in BALB/cJ mice. J Parasitol 90:79–84. doi:10.1645/GE-3255
Flessner MF, Fenstermacher JD, Dedrick RL, Blasberg RG (1985) A distributed model of peritoneal-plasma transport: tissue concentration gradients. Am J Physiol 248:F425–F435
Fraga CM, Costa TL, Bezerra JCB, Lino Junior RS, Vinaud MC (2012) Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci. Exp Parasitol 130:146–151. doi:10.1016/j.exppara.2011.11.001
Freeman RS (1962) Studies on the biology of Taenia crassiceps (Zeder, 1800) Rudolphi, 1810 (Cestoda). Can J Zool 40:969–990
Heiderstadt KM, Blizard DA (2011) Increased juvenile and adult body weights in BALB/cByJ mice reared in a communal nest. J Am Assoc Lab Anim Sci 50:484–487
Landa A, Jiménez L, Willms K, Jiménez-García LF, Lara-Martínez R, Robert L, Cirioni O, Baranska–Rybak W, Kamysz W (2009) Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. Mol Biochem Parasitol 164:126–130. doi:10.1016/j.molbiopara.2008.12.006
Maizels RM, Yazdanbakhsh M (2003) Immune regulation by helminth parasites: cellular and molecular mechanisms. Nature Rev Immunol 3:733–744. doi:10.1038/nri1183
Mariner SE, Morris DL, Dickson B, Bogan JA (1986) Pharmacokinetics of albendazole in man. Eur J Clin Pharm 30:705–708
Matthaiou DK, Panos G, Adamidi ES, Falagas ME (2008) Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis 2(3):e194. doi:10.1371/journal.pntd.0000194
Morales-Montor J, Escobedo G, Vargas-Villavicencio JA, Larralde C (2008) The neuroimmunoendocrine network in the complex host–parasite relationship during murine cysticercosis. Curr Top Med Chem 8:400–407. doi:10.2174/156802608783790866
Mount PM (1968). Rostellar morphogenesis in two strains of Taenia crassiceps (Zeder, 1800) Rudolphi, 1810 (Cestoda: Taeniidae). M.S. thesis, Wake Forest University, Winston-Salem, North Carolina
Palomares F, Palencia G, Pérez R, Gonzáles-Esquivel D, Castro N, Cook HJ (2004) In vitro effects of albendazole sulphoxide and praziquantel against Taenia solium and Taenia crassiceps cysts. J Antimicrob Chemother 48:2302–2304. doi:10.1128/AAC.48.6.2302-2304.2004
Palomares F, Palencia G, Ambrosio JR, Ortiz A, Cook HJ (2006) Evaluation of the efficacy of albendazole sulphoxide and praziquantel in comination on Taenia crassiceps: in vitro studies. J Antimicrob Chemother 57:482–488. doi:10.1093/jac/dki484
Palomares-Alonso F, Piliado JC, Palencia G, Ortiz-Prata A, Cook HJ (2007) Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts. J Antimicrob Chemother 59:212–218. doi:10.1093/jac7dk1463
Palomares-Alonso F, Rivas González C, Bernad-Bernad MJ, Castillo Montiel MD, Palencia Hernández G, González-Hernández I, Castro-Torres N, Pinzón Estrada E, Jung-Cook H (2010) Two novel ternary albendazole–cyclodextrin–polymer systems: dissolution, bioavailability and efficacy against Taenia crassiceps cysts. Acta Trop 113:56–60. doi:10.1016/j.actatropica.2009.09.006
Ramirez-Bon E, Merchant MT, Gonzalez-Del Pliego M, Cañedo M (1982) Ultrastructure of the bladder wall of the metacestode of Taenia solium. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F (eds) Cysticercosis: present state of knowledge and perspectives. Academic, New York, pp 261–280
Reyes JL, González MI, Ledesma-Soto Y, Satoskar AR, Terrazas LI (2011) TLR2 mediates immunity to experimental cysticercosis. Int J Biol Sci 7:1323–1333
Rodríguez-Sosa M, Saavedra R, Tenorio EP, Rosas LE, Satoskar AR, Terrazas LI (2004) A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps. Infec Immun 72:4552–4560. doi:10.1128/IAI.72.8.4552-4560.2004
Sanchez-Alvarado A (2006) Planarian regeneration: its end is its beginning. Cell 124:241–245. doi:10.1016/j.cell.2006.01.012
Smyth JD, McManus DP (1989) The adult cestode: special structural features relevant to its physiology. In: Smyth JD, McManus DP (eds) The physiology and biochemistry of cestodes, 1st edn. Cambridge University Press, Cambridge, pp 5–22
Sotelo J, del Brutto OH, Penagos P, Escobedo F, Torres B, Rodriguez-Carbajal J, Rubio-Donnadieu F (1990) Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 237:69–72
Stettler M, Fink R, Walker M, Gottstein B, Geary TG, Rossignol JF, Hemphill A (2003) Antimicrob Agents Chemother 47:467–474. doi:10.1128/AAC.47.2.467-474.2003
Takayanagui OM, Jardim E (1992) Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 49:290–294. doi:10.1001/archneur.1992.00530270106026
Terrazas LI (2008) The complex role of pro- and anti-inflammatory cytokines in cysticercosis: immunological lessons from experimental and natural hosts. Curr Top Med Chem 8:383–392. doi:10.2174/156802608783790848
Trejo-Chávez H, García-Vilchis D, Reynoso-Ducoing O, Ambrosio JR (2011) In vitro evaluation of the effects of cysticidal drugs in the Taenia crassiceps cysticerci ORF strain using the fluorescent cell tracker CMFDA. Exp Parasitol 127:294–299. doi:10.1016/j.exppara.2010.06.025
Vargas-Villavicencio JA, Larralde C, De León-Nava MA, Escobedo G, Morales-Montor J (2007) Tamoxifen treatment induces protection in murine cysticercosis. J Parasitol 93:1512–1517. doi:10.1645/GE-1191.1
Walker M, Rossignol JF, Torgerson P, Hemphill A (2004) In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes. J Antimicrob Chemother 54:609–616. doi:10.1093/jac/dkh386
Willms K, Zurabian R (2010) Taenia crassiceps: in vivo and in vitro models. Parasitology 137:335–346. doi:10.1017/S0031182009991442
Zurabian R, Aguilar L, Jiménez JA, Robert L, Willms K (2008) Evagination and infectivity of Taenia crassiceps cysticerci in experimental animals. J Parasitol 94:1–6. doi:10.1645/GE-1239.1
Zurabian R, Espinosa De Los Monteros A, Landa A, Willms K (2013). Variability between infrapopulations of infective and non-infective Taenia crassiceps WFU cysticerci. WebmedCentral Parasitology 4(2):WMC004064. Available from http://www.webmedcentral.com/article_view/4064
Acknowledgments
The authors wish to thank L. Robert and J.A. Jimenez for providing technical assistance in preparing microscopy slides and animal management. The present study was supported by CONACyT 79686.
Conflict of interest statement
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zurabian, R., Aguilar-Vega, L., Terrones Vargas, E. et al. In vivo albendazole treatment of Taenia crassiceps cysticerci strain WFU: proliferation, damage, and recovery. Parasitol Res 112, 3961–3968 (2013). https://doi.org/10.1007/s00436-013-3589-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-013-3589-7